Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Aurobindo Pharma Ltd ( (IN:AUROPHARMA) ) has shared an announcement.
Aurobindo Pharma Limited has announced its participation in an upcoming investor group plant visit scheduled for February 21, 2025, at their facility in Jadcherla. This engagement aims to foster transparency and investor relations, although no unpublished price-sensitive information will be disclosed during the visit, ensuring compliance with regulatory standards.
More about Aurobindo Pharma Ltd
Aurobindo Pharma Limited is a prominent player in the pharmaceutical industry, known for its manufacturing and marketing of generic pharmaceuticals and active pharmaceutical ingredients. The company focuses on delivering high-quality medications across various therapeutic segments globally.
YTD Price Performance: -16.40%
Average Trading Volume: 18,741
Current Market Cap: 656.2B INR
See more data about AUROPHARMA stock on TipRanks’ Stock Analysis page.